Analysis of Cancer Risk and BRCA1/2 Mutation Prevalence in kConFab Families
Author Information
Author(s): Mann Graham J, Thorne Heather, Balleine Rosemary L, Butow Phyllis N, Clarke Christine L, Edkins Edward, Evans Gerda M, Fereday Sián, Haan Eric, Gattas Michael, Giles Graham G, Goldblatt Jack, Hopper John L, Kirk Judy, Leary Jennifer A, Lindeman Geoffrey, Niedermayr Eveline, Phillips Kelly-Anne, Picken Sandra, Pupo Gulietta M, Saunders Christobel, Scott Clare L, Spurdle Amanda B, Suthers Graeme, Tucker Kathy, Chenevix-Trench Georgia
Primary Institution: The Kathleen Cuningham Consortium for Research in Familial Breast Cancer
Hypothesis
The study aims to assess the risk of breast cancer and the prevalence of BRCA1 and BRCA2 mutations in families with multiple cases of breast cancer.
Conclusion
The kConFab resources are valuable for researchers, showing that high calculated risks correlate with breast cancer occurrence in BRCA1 and BRCA2 mutation-positive families.
Supporting Evidence
- Among the 812 families with at least one germline sample collected, 31% carry a pathogenic or splice-site mutation in BRCA1 or BRCA2.
- The mean number of germline DNA samples collected per family is nine.
- Data are available for 11,422 consented participants, including 900 carriers of pathogenic or splice site BRCA1 or BRCA2 mutations.
Takeaway
This study looks at families with breast cancer to see how often they have certain gene mutations and how likely they are to get breast cancer.
Methodology
Data and biospecimens were collected from multiple-case breast cancer families in Australia and New Zealand, and the Tyrer-Cuzick algorithm was used to assess breast cancer risk.
Potential Biases
Potential bias due to the non-random selection of families based on clinical criteria.
Limitations
The study is not population-based and relies on clinical identification of high-risk individuals, which may not represent the broader population.
Participant Demographics
The cohort includes individuals from families with multiple cases of breast cancer, with a majority being female participants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website